In response to news of a ransomware attack on eResearch Technologies, a company whose clinical trials software is widely used in clinical trials, including in AstraZeneca’s Covid-19 vaccine trial and in Bristol Myers Squibb in a multi-company initiative to develop rapid COVID-19 testing, experts offer perspective.
About the Author
The opinions expressed in this post belongs to the individual contributors and do not necessarily reflect the views of Information Security Buzz.
